Search results
Results from the WOW.Com Content Network
Serious side effects may include anaphylaxis, liver problems, depression, and muscle breakdown. [4] [5] Use in pregnancy and breastfeeding is of unclear safety. [10] Ezetimibe works by decreasing cholesterol absorption in the intestines. [5] Ezetimibe was approved for medical use in the United States in 2002. [4] It is available as a generic ...
Liquid oxygen is the name of a product that is a solution of hydrogen peroxide [1] and other compounds including sodium chloride (common salt) [2] [3] that claims to help with "jet lag, fatigue, altitude sickness, headaches, hangovers, youthful skin, energy, and insomnia".
Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [ 1 ]
Cons of volume eating The key to doing volume eating successfully is making sure you get a proper balance of nutrients. “You want to make sure that their diet is not lacking in protein and fat ...
Medical use liquid oxygen airgas tanks are typically 2.4 MPa (350 psi). [citation needed] All equipment coming into contact with high pressure oxygen must be "oxygen clean" and "oxygen compatible", to reduce the risk of fire. [3] [4] "Oxygen clean" means the removal of any substance that could act as a source of ignition. "Oxygen compatible ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
If you’re in the clear to take berberine, there are a few potential side effects to consider. Berberine can upset your gastrointestinal system, causing symptoms like: nausea, diarrhea ...
With median follow-up of 6 years, simvastatin+ezetimibe was found to reduce the primary outcome of CV mortality, major CV event, or nonfatal stroke (34.7% vs. 32.7%; P=0.016; NNT 50 per 7 years or NNT 350 per 1 year ). There was no reduction in all-cause or CV mortality with simvastatin+ezetimibe, though there was a reduction in MI and stroke. [6]